SEC Company Response from NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC) — Dec 20, 2012
NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: Dec. 20, 2012 · CIK: 0001379006 · Accession: 0001144204-12-068938
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-184626
Letter
Via Edgar Only United States Securities and Exchange Commission Attention: Jeffrey P. Riedler, Re: NanoViricides, Inc. Registration Statement on Form S-3 Filed on October 26, 2012 File No. 333-184626
Dear Mr. Riedler:
Please be advised that the undersigned is the duly elected Chief Executive Officer of NanoViricides, Inc. (the “Registrant”). Having been advised that the Commission has no further comments to the Registrant’s Form S-3 Registration Statement, the Registrant hereby requests acceleration of the effective date of the Registration Statement to Wednesday, December 26, 2012 at 9:00 a.m., or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have any questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate to contact me.
Very truly yours,
/s/ Eugene Seymour, MD, MPH
Show Raw Text
CORRESP
1
filename1.htm
Nanotechnology-Enabled Targeted Viricides”
Publicly Traded Company, “NNVC”
www.nanoviricides.com
December 20, 2012
Via Edgar Only
United States Securities and Exchange Commission
Mail Stop 6010
Washington, D.C. 20549
Attention: Jeffrey P. Riedler,
Assistant
Director
Re: NanoViricides, Inc.
Registration
Statement on Form S-3
Filed
on October 26, 2012
File
No. 333-184626
Dear Mr. Riedler:
Please be advised that
the undersigned is the duly elected Chief Executive Officer of NanoViricides, Inc. (the “Registrant”). Having been advised
that the Commission has no further comments to the Registrant’s Form S-3 Registration Statement, the Registrant hereby requests
acceleration of the effective date of the Registration Statement to Wednesday, December 26, 2012 at 9:00 a.m., or as soon thereafter
as practicable.
The Registrant hereby acknowledges that:
· should
the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission
from taking any action with respect to the filing;
· the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve
the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the
Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Should you have any
questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate
to contact me.
Very truly yours,
/s/ Eugene Seymour, MD, MPH
Eugene Seymour, MD, MPH
135 Wood Street, Ste. 205, West Haven, CT 06516. Tel./Fax: 203-937-6137.